Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?

Jagannadha Avasarala, Phenu Zachariah

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Maintaining adequate levels of vitamin D may have a protective effect and lower the risk of multiple sclerosis (MS). For patients with MS, maintaining an adequate level of vitamin D level is probably associated with lessening of the frequency and severity of their symptoms. However, what remains unclear is whether if this is true across all racial/ethnic backgrounds. In African-Americans (AAs) this effect is not only absent but curiously enough, low levels of vitamin D do not matter since the bioavailability of this molecule in AA subjects is normal. It is this paradox that led to this brief report and we suggest more research and database construction based on race/ethnicity be done, as a first step to understand the biological mechanisms that confer or negate the effect of vitamin D levels in MS.

Original languageEnglish
Pages (from-to)417-418
Number of pages2
JournalJournal of the Neurological Sciences
Volume358
Issue number1-2
DOIs
StatePublished - Nov 1 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier B.V.

Keywords

  • African-Americans
  • Big data
  • Caucasians
  • Databases
  • Multiple sclerosis
  • Vitamin D deficiency
  • Vitamin D supplementation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?'. Together they form a unique fingerprint.

Cite this